Huntington’s disease: novel therapeutic strategies targeting the mutant huntingtin production pathway

Access to the full content of this site is available only to registered healthcare professionals. Register to read more
No disease-slowing treatment exists for Huntington’s disease, but its monogenic inheritance makes it an appealing candidate for the development of therapies targeting processes close to its genetic cause. Huntington’s disease is caused by CAG repeat expansions in the HTT gene, which encodes t...